Autopsy report · NCT00229866
Feeding After Neonate Surgery Review
Cause of deathOther
“sufficient data gathered for study conclusion”
Life of this trial
- Ran for about 10 months before it stopped.
- 90 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- Children's Healthcare of Atlanta
- Sponsor type
- University, hospital or other
- Conditions
- Congenital Disorders
- Participants
- 90
- Sites
- 1
- Countries
- United States
Trials that died the same way
- A Study of the Safety and Efficacy of MK-3577 in Participants With Type 2 Diabetes Mellitus (MK-3577-009)
“Upon interim analysis, sufficient data was accrued to assess study hypotheses.” - Prevalence and Clinical Spectrum of the 22q11 Deletion
“sufficient data collected” - A Single Ascending Dose Trial of CVL-936 in Healthy Subjects
“Sufficient data has been obtained to meet current objectives” - Erythropoietin in Premature Infants to Prevent Encephalopathy
“The study was concluded as planned upon reaching its predetermined endpoint, which included the completion of data collection and achievement of the necessary sample size for statistical significance.” - AI-assisted cEEG Diagnosis of Neonatal Seizures in Neonatal Intensive Care Unit
“The other study was concluded as planned upon reaching its predetermined endpoint, which included the completion of data collection and achievement of the necessary sample size for statistical significance.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.